Frailty and health outcomes in older people initiating an oral anticoagulant

Not Applicable

• Conditions: atrial fibrillation; thromboembolism; stroke; haemorrhage; Cardiovascular - Other cardiovascular diseases; Blood - Other blood disorders; Stroke - Ischaemic

• Registration Number: ACTRN12616000452493
• Lead Sponsor: Clinical Pharmacology, Royal Adelaide Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

commencement of an oral anticoagulant in the past 4 weeks

Exclusion Criteria

previous use of warfarin or other oral anticoagulants in the previous 12 months. severe hearing impairment such that the participant cannot participate in an interview or where the investigator feels that it will not be possible to collect adequate follow-up information.

Study & Design

• Study Type: Observational
• Study Design: Not specified